Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

recombinant hematopoietic growth
factors
Th.B8.4 108
recombinant proteins
M o.A. 1032, M o.A. 1090, M o.A. 1092,
Mo.A.285, Mo.B. I184, Mo.C. 1676,
ThA. 15 I,Th.A.382,Th.A.4029,
We.A. I152, We.A,3056
recombinant soluble CD4 (rCD4)
Mo.A. 1008
recombination
Tu.A.2076,Tu.A.372
reconstitution, immunologic
We.B.29 I
rectal ulcers
Th.B.4292, We.B.32 10
red blood cells
Mo.B. 1 19 I,Tu.D.2840
refugees
Pub.C. I 226,Th.C.4424,Th.C.4437,
Th.C.4564, Th.C.4849, Tu.C.26 I17,
Tu.C.2674, Tu.D.24 I, Tu.D.242,Tu.D.243,
Tu.D.29 I I, We.D.3777
regulation
Mo.A. 1025, Mo.A. 1026, Mo.A. 1035,
Mo.A. 1038, Mo.A.5Q
Reiter's syndrome
Mo.B.1300
relapse
Mo.B. 11I89, Mo.B. I1219, Mo.B. 1239,
Mo.D. I1825, Pub.B. I1086, Th.C.4666,
We.C.3497
religion
MoD. I1898, Pub.C. 11I99, Pub.C. 1 21I8,
Pub.C. I1226, Pub.D. I1294, Pub.D. I135 1,
Pub.D. I1375, Pub.D. I1377, Pub.D. 1462,
Th.B. I 96,Th.C.4429,Th.C.4466,
Th. D.49 29, Th. D.5 13 8, Tu. D.2704,
Tu.D.2797,Tu.D.283 I,Tu.D.2832,
Tu.D.2833,Tu.D.2834,Tu.D.2838,
Tu.D.2839,Tu.D.2840,Tu.D.460,
We.D.3692, We.D.3698, WeD.3788,
We.D.3803
religious institutions
Mo.B.1380, Pub.C. 1 145, Pub.C. I1236,
Pub.D. I1375, Pub.D. 1 378, Th.C.47 I19,
Th.D.4996,Tu.D.2835,Tu.D.2839,
Tu.D.2842,Tu.D.2843,Tu.D.2862,
We.D.377 I
renal disease
Mo.B. 1263, Mo.B. 1290, Mo.8. 1302,
Mo.B. I 328,Th.C.225,Tu.B.2232,
Tu.B.2233
replication, kinetics
Mo.A. 1040, Mo.A.382, Mo.A.383,
Tu.A. 142, We.A.263, We.A.270,
We.A.3088, We.B.530
replication, other
Mo.A. I1038, Th.A. I105, Th.A.4063,
Th.C.4429,Tu.A.2024, Tu.A.2040
replication rate
Mo.A. 14 1,Th.A. I 45,Tu.B.2220, We.B.530,
We.C.3450
reporting
Mo.C. 1500, MoC,1554, MoC. 1557,
MoC. 1564, MoC. 1565, Mo.C.202,
Mo.C.204, Mo.C.206, Mo.C.2 12,

MoD. I1869, Mo.D. I1880, Pub.D. I1502,
Th.C.4383,Th.C.4506,Th.C.4524,

Th.C.4834,Th.D.4992, Th.D.5003,
Th. D.5009, Tu.A.20 I9, Tu. B. 2151,
Tu.D.27 I 5,Tu.D.2805,Tu.D.603,
We.C.3556, We.D.3679, We.D 3780,
We.D.3847, We.D.3885, We.D.389 I,
We.D.470
resistance, drug
Mo.A. 1051, Mo.A. 1065, Mo.A. 1075,
M o.A. 1077, Mo.A.I I 110, Mo.A. I1I 12,
Mo.A.I 113, Mo.A.l1 14, Mo.A. 1115,
Mo.A.272, Mo.A.380, Mo.A.38 I,
Mo.B.I112, Mo.B.I1123, Mo.B.1219,
Mo.B. 1228, Mo.B. I1310, Mo.B. 1362,
Mo.B.170, Mo.B.4 14, Mo.C. 161 1,
Mo.C. I1644, Mo.C. I1646, Th.A. IS I,
ThA. I 5 3, Th.A. I154, Th.A. 39 3,Th. B. 306,
Th.B.4 I 66,Th.B.4 I 96,Th.B.4207,
Th. B.4342, Th. B.4343, Th. B.4347,
Th.B.4348,Th.B.4349,Th.B.4353,
Th.B.4354,Tu.B. I 82,Tu.B. I 93,Tu.B.2 I122,
Tu.B.2 I124, Tu.B.2 I197, Tu.B.2 I198,
Tu. B.2200, Tu.B.22 I13, Tu. B.2267,
Tu.C,2606, We.A. I152, We.B.304,
We.B.3 11I6, We.B.3 134, We.B.3305
resource allocation
Mo.D. I1825, Pub.C. I 274,Th.C.20 1,
Th.C.4797, Th.C.48 I16, Th.C.4836,
Th.D.4968, Th.D.4976, Th.D.5006,
Tu.B.2 I1S8, We.D.3720, We.D.3840,
We.D.3847, We.D.3892
respiratory therapy,
Mo.B. I359,Tu.B.2290
resting energy expenditure
Mo.B. I 396,Tu.B.2387, We.B. 183
restriction fragment length
polymorphism (RFLP)
Th.A.4053,Th.C.33 I,Tu.A. I 65, u.A.2065
retinitis, SEE cytomegalovirus
Mo.B. I 2I8,Th.B.305,Tu.B.21I83,
Tu. B.2 I84
retinoids
Mo.B.432,Th.B.4238, Tu.B.2220,
Tu.C.2592, We.B. I182, We.B.324 I
retroviral genomes
Mo.A. 101 I, Mo.A.523, Pub.A. 1004,
Tu.B.3 I15
retroviral replication
Mo.A. 101 1, Mo.A. 1022, Mo.A. 1075,
Mo.A. 1082, Mo.A. I1100, Mo.A.503,
TuA.5 I, Tu.A.5 I13, We.A.270, We.B.3290
retroviruses, other, SEE individual
names
Mo.A. 1035,Tu.A.21 I I
rev gene
Mo.A. 1038, Mo.A. 1052
reverse transcriptase
Mo.A. 1012, Mo.A. 1014, Mo.A.1(350,
Mo.A. IOSI, Mo.A. 1059, Mo.A. 1061,
Mo.A. 1077, Mo.A. I1I12, Mo.A. I I IS,
Mo.A. 164, Mo.A.38 1, Mo.B. I 127,
Mo.B. 1177, Pub.A. 1001, Pub.A. 1002,
Pub.A 1I003, Pub.A. I 0 I16, Th.A. I15 I,
Th.B8.294, Th.B.435 I, Tu.A. I162, Tu.A.2037,
Tu.ASO I,Tu.C.2606, We.B.3 I115,
We.B.3 131,We.B.3 132
rgpl6O vaccine
Th.B. 177, Th. D.5064, Tu.A.2 73, Tu. B. I72

Pub.C. 11I71I, Pub.D. I1343, Th.D.245,
We.D.3772

risk factors
Mo.B. 1208, Mo.B. I216, Mo.B. 1277,
MoC.1406, Ma.C. 141 2, Ma.C. 1414,
Mo.C. 1416, Mo.C. 1422, MoC. 1433,
MoC.1444, Mo.C,1463, Ma.C. 1468,
Mo.C. 1472, Ma.C. I 182, Ma.C.1485.
Mo.C. I5 I I, MCI 1'I!,.Mo.C.1I527,
Ma.C. I546, Ma.C. I1554, Mo.C. I1557,
Mo.C. I1588, MaloC. I1589, Mo.C. I161 1,
MoC. I1625, MoC. I1635, MoC. I1666,
Mo.C. 1675, Mo.C.2 12, Mo.C.225,
Mo.C.345, Mo.C.453, Mo.D. 1694,
Mo.D. I1695, Mo.[3. I698, Mo.D. I1709,
Mo.D.171 2, MoD. 1717, Mo.D. 1718,
Mo.D.1723, Mo.D. 1728, Mo.D. 1732,
Mo.D. I1864, Mo.D.49 I, Mo.D.495,
Pub.C.I 1 0 0, Pub.C.lI l0 I, Pub.C. I 115,
Pub.C. I1I22, Pub.C. I1I24, Pub.C. I1I28,
Pub.C.I1134, Pub.C.I1149, Pub.C.I1ISO,
Pub.C. I1I70, Pub.C. I1I78, Pub.C. I1I96,
Pub.C. I1244, Pub.C. I1289, Pub.D. I1292,
Pub.D. 1294, Pub.D.131 I, Pub.D. 13 17,
Pub.D. 1337, Pub.D. 1353,,Pub.D. 142
Pub.D. I 496, Th. B. I I S, Th.B.4202,
Th.B.42 I16, Th.B.42 3 I, PLC. I122,
Th.C. I 23,Th.C.225,Th.C.334,Th.C.340,
Th.C.4367, Th.C.4422, Th.C.4446,
Th.C.4466, Th.C.4572, Th.C.4602,
Th.C.4748, Th.C.4839, Th.D.363,
Th.D.444, Th.D.457,T-h.D.49 14,
Th. D.49 29,-Th. D.49 3 I, Tu.A. I152, Tu. B. 113,
Tu.B. II 4,Tu.B. 171 Tu.B. I 86,Tu.B.22 IS,
Tu. C.2388,Tu.C.2390,Tu.C.2393,
Tu.C.2399, Tu.C.2406, Tu.C.2408,
Tu.C.24 I12, Tu.C.24 I14, Tu.C.2427,
Tu.C.2430, Tu.C.2432, Tu.C.2435,
Tu.C.2447,Tu.C.245 I, Tu.C.2453,
Tu.C.2464, Tu.C.2465, Tu.C.2479,
Tu.C.2495, Tu.C.2497, Tu.C.2498,
Tu.C.2499, Tu.C.2503, Tu.C.25 I15,
Tu.C.25 37, Tu.C.2540, Tu.C.2547,
Tu.C.2548,Tu.C.2553,Tu.C.2563,
Tu.C.2565, Tu.C.2620, Tu.C.2629,
Tu.C.2632,Tu.C.2645,Tu.C.2650,
Tu.C.2660, Tu.C.2667, Tu.C.2669,
Tu.C.2683, Tu.C.2693, Tu.C.573, Tu.D. 134,
Tu.D.2708, Tu.D.290 I,We.B.3245,
We.B.3289, We.B.540, We.C.22 I,
We.C.3437, We.C.3456, We.C.3479,
We.C.3480, We.C. 3SS8, We.C.3574,
We.C.563, We.D.36 I, We.D.3656
risk perception
MoCISI I, MoCIS12, Mo.D.1693,
Mo.D.1701, Mo.D. 1704, Mo.D. 1706,
Mo.D.171 1, Mo.D. 1729. Mo.D. 1752,
Mo.D. I191I9, Mo.D.247, Pub.C. I1124,
Pub.C.I 134, Pub.C.l1174, Pub.C.l1187,
Pub.D. 131 7, Pub.D. 131 8, Pub.D. I1329,
Pub.D. 1386, PuS.D. 1390, Pub.D. 1403,
Pub.D. 1443, Pub.D. I1444, Pub.D. 1447,
Pub.D. I 448, Th.C.2 I10, Th.C.44 19,
Th.C.4425, Th.C.4444, Th.C.45 I18,
Th.C.4563, Th.C.4572, Th.C.4597.
Th.C.4603, Th.C.4604, Th.C.47 17,
Th.D.244,Th.D.445,Th.D.455,Th.D.5 I161,
Tu.B.2 I 53,Tu.C.239 I,Tu.C.2408,
Tu.C.2443,Tu.C,2499,Tu.C.25 I12,

Th.C.4469,Th.C.4475,Th.C.4502,
Th.C.4503,Th.C.4629,Th.C.4653,

Th.C.4658,Th.C.467 I.Th.C.4674,
Th.C.4678,Th.C.468 I,Th.D.36 I,
Th.D.49 I15, Th.D.492 I,Th.D.50 16,
Tu.B.2 I 45,Tu.C.239 I,Tu.C.2397,
Tu.C.24 I 3,Tu.C.2553,Tu.C.2594,
Tu.C.26 I 6,Tu.C.2686,Tu.C.453,lu.C.454,
Tu.D.27 I I,Tu.D.2770,Tu.D.2885,
Tu.D.2953,Tu.D.47 I, We.C.3479,
We.C.3480, We.C.3497, We.C.35 12,
We.C.35 I13, We.C.3540, We.C.3558,
We.C.3565, We.C.3567, We.C.44 I.
We.C.445, We.D.3 772
RNA, antisense
We.A.275
RNA PCR
Mo.A. 1014, Mo.A. 1083, Mo.B. I1120,
Mo.B. I1I52, Mo.B. I1267, Mo.B. 1326,
Mo.B. I1331, Mo.B, I337, Mo.B. I134 I,
Mo.B.1347, Mo.B, I376, Mo.B. 1379,
Mo.B.293, Mo.B.295, Mo.B.3 I14,
Mo.C.323,Th.A. 14 1,Th.A.382, Th.A.4032,
Th.A.4038, Th.A.4045, Th.B.4 106,
16.8.4 1 I8,Th.B.4 I 82,Th.B.4335,
Th. B.4 3 38, Th. B.4340, Th. B.4 347,
Th.8B.4352, Tu.B.2267,Tu.B.2 332,
Yu.C.2597,Tu.C.269 I,Tu.C.345,
We.A. I140, We.A.3052, We.A.522,
We.A.523, We.B. I192, We.B.3 I2 7,
We.B.3 I15, We.B.3 I9 8, We.B.3350,
We.B.3383, We.B.3385, We.B.4 14,
We.B.530, We.C.330, We.C.335,
We.C.35 I4
RNA probe
Mo.A. I 032,Th.B.4339,Th.B.4352,
We.A.275, We.B.3385
RNase H
Mo.B.l 127
roxithromicin
Th.B.421 I
RT-PCR method
Mo.A.I IlOS, Mo.A.161. Mo.B. 1S52,
Th.A.4033, Th.A.40 34, Th.A.4038,
Th.A.4044, Th.A.4065, T.B. I 76, Tu.A. 162,
Tu.B.2372, We.A.3 I107. We.A.523,
We.C.3438
rural areas
Mo.C.1409, Mo.C.14 10, Mo.C.14 19,
Mo.C.444, Mo.C.454. Mo.D. 1729,
Mo.D.1787. Mo.D. 1901, Mo.D. 1906,
Mo.D.24 1, Pub.C. I1227. Pub.C. I1228.
Pub.C. I1248. Pub.C. I1282, Pub.D. 1348,
Pub.D. I 466,Th.B.4 I130Th.C.4367,
Th.C.4527. T h.C.4632, Th.C.4683.
Th.D.4888, Th.D.4904.Th.D.4978,
Th. D.5067, Th.D.5 I 47, Tu. C.2478,
Tu.C.2628,Tu.D.244,Tu.D,27 I12.
Tu. D. 2904, Tu. D.29 20, Tu. D. 2924,
We.B.3 I188, We.B.3225, We.D.3637,
We.D.3677, We.D.3689, We.D.3844
safer sex
Mo.B, I1I67, Mo.D I175 I, Mo.D. I181I6,
Mo.D. I1829. Mo.D. I1834, Mo.D. I1876,
Mo.D.490. Pub.C. I1162. Pub.C. I1I66.
Pub.C.l1195. Pub C.1243, Pub.C, 1252,
Pub.D.13 1 2, Pub.D. 1369, Pub.D.1383,
Pub.D.1441, Pub.D.1443, Pub.D. 1450,
Tb.C.424.Tb.C.433. Tb.C.4360,

We.B.3 I173, We.B.33O3, We.B.3306

~0
c
C
0
c
0
0
C
C

497